Effect of Brovana and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
This will be a double-blind crossover trial in 20 patient with stable COPD. Data from this
study will provide proof-of-concept information on whether the (anticipated) additional
bronchodilator effect of Brovana added to tiotropium will lead to a meaningful improvement in
the patient-centered outcome, exercise capacity. This study will only evaluate the effects of
short-term (1-week) administration of Brovana. If results are positive, it would provide
preliminary data for further, multicenter investigations.